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Abstract
Purpose: RAGE regulates pro-inflammatory responses in diverse cells and tissues. This study has investigated if RAGE plays a
role in immune cell mobilization and choroidal neovascular pathology that is associated with the neovascular form of age-
related macular degeneration (nvAMD).
Methods: RAGE null (RAGE2/2) mice and age-matched wild type (WT) control mice underwent laser photocoagulation to
generate choroidal neovascularization (CNV) lesions which were then analyzed for morphology, S100B immunoreactivity
and inflammatory cell infiltration. The chemotactic ability of bone marrow derived macrophages (BMDMs) towards S100B
was investigated.
Results: RAGE expression was significantly increased in the retina during CNV of WT mice (p,0.001). RAGE2/2 mice
exhibited significantly reduced CNV lesion size when compared to WT controls (p,0.05). S100B mRNA was upregulated in
the lasered WT retina but not RAGE2/2 retina and S100B immunoreactivity was present within CNV lesions although levels
were less when RAGE2/2 mice were compared to WT controls. Activated microglia in lesions were considerably less
abundant in RAGE2/2 mice when compared to WT counterparts (p,0.001). A dose dependent chemotactic migration was
observed in BMDMs from WT mice (p,0.05–0.01) but this was not apparent in cells isolated from RAGE2/2 mice.
Conclusions: RAGE-S100B interactions appear to play an important role in CNV lesion formation by regulating pro-
inflammatory and angiogenic responses. This study highlights the role of RAGE in inflammation-mediated outer retinal
pathology.
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Introduction
The early stages of age-related macular degeneration (AMD)
are characterised by progressive dysfunction of the retinal pigment
epithelium (RPE) in unison with changes to underlying Bruch’s
membrane leading to deposition of sub-RPE drusen and basal
laminar deposits, photo-oxidative lipofuscin and loss of retinal
pigment [1]. While the pathogenesis of AMD remains ill-defined,
it is recognised that age-related RPE dysfunction in combination
with progressive inflammatory and oxidative damage are of
central importance [2]. In the neovascular (wet) form of AMD
(nvAMD) RPE-Bruch’s membrane damage is associated with
choroidal neovascularisation (CNV) which is stimulated by pro-
inflammatory cascades and macrophage infiltration in the outer
retina [3].
RAGE is a member of the immunoglobulin super-family with a
high affinity for several ligands including advanced glycation
endproducts (AGEs), S100B, high-mobility group box-1 (HMGB-
1), amyloid-b and Mac-1 [4–6]. As a component of the innate
immune response, this receptor is expressed in many tissues and
regulates a range of pathophysiological responses linked to
pathways such as ERK1/2, MAP kinases, P38 and JAK/STAT,
downstream activation of NFkB, induction of pro-inflammatory
cytokines and generation of reactive oxygen species [7]. RAGE is
associated with Alzheimer’s disease, cardiovascular disease and
diabetic vasculopathy [8] and recent evidence also indicates that
this receptor could play an important role in tumour angiogenesis
[9], atherosclerosis [10] and some microvascular disorders [11].
In the normal retina, RAGE expression occurs predominantly
in the Mu¨ller glia although levels may become elevated in diabetic
conditions [12,13]. RAGE is constitutively expressed on RPE and
levels increase during age-related pathology, especially in cells
adjacent to drusen [14–16]. Also in RPE in vitro, exposure to
RAGE-ligands (AGEs or S100B) induces expression of angiogenic
factors [17]. Many RAGE ligands occur in the retina as a normal
consequence of ageing. For example, AGE-modified proteins
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accumulate at the RPE-Bruch’s membrane axis [18,19] where
they are likely to have an important pathogenic role in the
development of AMD [18]. AGEs are also increased in RPE,
drusen and Bruch’s membrane from ageing eyes and in patients
with AMD and adduct formation has been linked with chronic
inflammation at the outer retina [20].
S100B interactions with RAGE are crucial for microglial
activation in inflammatory brain pathology although at low
concentrations S100B functions as a neurotrophic factor indepen-
dently of RAGE [21]. The importance of S100B in the retina is
much less well understood although it occurs in glia and acts as a
calcium regulator in association with photoreceptor guanylate
cyclase [22]. Recent studies have also demonstrated that glial-
linked S100B is increased in diabetic retina where it can regulate
inflammatory signaling via RAGE [13]. Similar responses have
been observed in retinal capillary endothelium [23]. In view of the
connection between RAGE and inflammation, the current study
has evaluated the hypothesis that this receptor and its interaction
with S100B plays a role in CNV. Using experimental in vivo and
in vitro approaches it is demonstrated that RAGE is associated
with sight-threatening angiogenic pathology.
Materials and Methods
Mice and CNV Induction
Wild type (WT) C57BL/6J mice were purchased from Harlan
Laboratories (UK) and maintained within the Biological Research
Unit at Queen’s University Belfast. The RAGE knockout mouse
(RAGE2/2) was generated as previously described [24,25] on an
SVEV1296C57BL/6 background (Taconic Inc, Germantown,
NY) and backcrossed to C57BL/6 mice for 5 generations. These
RAGE2/2 mice were shown to possess the Crb1 gene Rd8
mutation via DNA sequencing. Because of the presence of the
RD8, the retina of both WT and RAGE2/2 mice were subjected
to histological investigation and Spectral Domain Optical Coher-
ence Topography (SD-OCT).
All experiments were performed in accordance with UK Home
Office and University Ethics Committee guidelines (Animals
[Scientific Procedures] Act, 1986). Specifically, Queen’s University
Animal Ethics Committee approved this study. 12 weeks old,
female WT and RAGE2/2 mice were used for each experimen-
tal set (n = 12/group). To create CNV, animals were anaesthetized
and rupture of Bruch’s membrane-choroid were achieved by laser
photocoagulation (Haag Streit BM 900 Slit Lamp and Argon laser;
Haag Streit, UK) using burns of 50 mm spot size (0.05 s duration,
250 mW) approximately 2 disc-diameters away from the optic
disc. Following CNV induction, confocal scanning laser ophthal-
moscopy (cSLO) (Heidelberg Engineering, UK) was used to obtain
infrared fundus images of the retina and angiography was also
conducted following intravenous injection of 10% sodium
fluorescein.
Retinal cross-sections in RAGE2/2 and WT mice were
acquired using the Spectralis Heidelberg OCT system (Heidelberg
Engineering, Heidelberg, Germany) at a 30u field of view. Mice
were anesthetized and the pupils were dilated by 1% tropicamide
and 2.5% Phenylephrine (Chauvin, Essex, UK). Corneas were
kept lubricated during the imaging session. High-resolution scans
were acquired at all four regions (dorsal, ventral, nasal and
temporal regions).
CNV Lesion Assessment
Mouse eyes were fixed in 4% paraformadehyde for overnight,
dehydrated with graded ethanol, and embedded in paraffin.
Complete sectioning of whole eyes were performed. 6 mm
thickness of sections were collected at regular intervals and
processed for hematoxylin and eosin (H&E) staining. 6 mice from
3 different litters for each age group were used for the purpose.
Age matched C57BL/6J were served as control. For evaluation of
CNV lesions, eyes were fixed in 4% PFA. Sections, retinal
flatmounts or RPE/choroid/sclera flatmouts were assessed using
isolectin B4, CD68. RAGE and S100B. Isolectin and CD68
positive microglia were divided into three basic morphological
categories using established methods [26]. At 1 week post-CNV
induction, WT and RAGE2/2 mice were sacrificed and eyes
were enucleated and fixed in 4% PFA. Posterior segment flat
mounts with neural retinal intact or removed were stained with
biotin conjugated isolectin B4 (Sigma, UK), CD68 (Abcam,
Cambridge, UK) and S100B (Abcam, Cambridge, UK) and with
the corresponding secondaries, including streptavidin Alexa Fluor
488 (Molecular Probes, Paisley, UK)) or Alexa Fluor 568 goat anti-
rabbit IgG. DAPI or propidium iodide (Sigma, UK) was also
added to locate the nuclear layers of the retina. Isolectin-localised
lesions were visualisation by confocal laser microscopy (Eclipse
TE2000-U confocal microscope, Nikon, UK). CNV lesion size was
quantified by measuring isolectin-positive area (NIS Elements,
Nikon, UK) of the RPE/Choroid/sclera flatmount.
In flatmounts with the retina intact, isolectin positive microglia
within or adjacent to the CNV lesion were quantified. The total
number of microglial cells counts were subdivided according to
whether the cells displayed dendritic or amoeboid morphology,
the latter indicating activation as previously described. The cells
were assessed in at least four Z-series images per specimen using a
Nikon Eclipse TE2000-U Confocal Microscope and divided into
two basic morphological categories as previously described [27].
Flat-mounts from at least 6 separate animals/treatment were
assessed and the total number of microglial counts were
subdivided according to whether the cells displayed dendritic or
amoeboid morphology, the latter indicating activation.
The eyes were enucleated at different time points post-lasering
and fixed in 2% PFA/PBS for two hours before embedded in
OCT for cryostat section. Sixteen mm thick cryosections were
blocked with 10% BSA for 30 mins. Rabbit anti-mouse RAGE
(1:100, Millipore, UK). Rabbit anti-mouse S100B (1:200, Abcam,
UK), biotin conjugated CD68 (1:200, BD biosciences, UK) were
incubated with the sections for overnight at 4uC. After washing in
PBS, these slides were incubated with goat anti-rabbit Alex Flour
594 (1:200, Invitrogen, UK), goat anti-rabbit Alex Flour 488
(1:200, Invitrogen, UK), streptavidin FITC (1:200, Vector Lab,
UK) or PI (1:200, Invitrogen, UK) for one hour at room
temperature. After washing in PBS, slides were covered with
Vectashield mounting medium (Vector Lab, UK) and evaluated
using confocal laser microscopy (Eclipse TE2000-U confocal
microscope, Nikon, UK).
Quantitative RT-PCR (qPCR)
As previously described [13], quantitative PCR was used to
assess expression of VEGF, RAGE, S100B, CSF-1 (MCSF-
1),MCP-1, IL-1b, TNFa, and IL-6 in retina from RAGE2/2
and WT mice. Total RNA was extracted from freshly dissected
retinas of RAGE2/2 and WT mice with or without laser-induced
CNV (n= 7 mice/group) using Tri-Reagent (Sigma, UK). The
Qiagen Quantitect reverse transcription system (Qiagen, West
Sussex, UK)) was used to synthesize cDNA, with 1 mg of RNA and
random primers, according to the manufacturer’s instructions.
qPCR was performed for quantitative analysis of mRNA
expression as previously described [13]. Sequence-specific primers
were designed using the program NCBI primer blast to amplify
VEGF (Forward: 59 AGGATGTCCTCACTCGGATG39;. Re-
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verse: 59 TCTGGAAGTGAGGCCAATGTG39), RAGE (For-
ward: 59GCCCGGATTGGAGAGCCACTTG39;. Reverse: 59
GAGGTTGAGTGGCCAGGCGTGC39), S100B (Forward: 59
TGCATGCTGGTCCCTGAGAATACTG39; Reverse
39GGTCCCCTCCTGCAGGTATGCC39), CSF-1 (MCSF-1)
(Forward: 59 ACTTGGAGCGGACAGCCCCTT39; Reverse:
TTGAAATACCGCGGGCCTCAGC39), MCP-1 (Forward: 59
TCACCTGCTGCTACTCATTCACCA39; Reverse: 59
AAAGGTGCTGAAGACCCTAGG GCA39), IL-1b (Forward:
39 GCCCATCCTCTGTGACTCAT39; Reverse 59 AGGCCA-
CAGGTATTTTGTCC39), TNFa (Forward: 59 CGTCAGCC-
GATTTGCTATCT39; Reverse: 59 CGGACTCCGCAAAGTC-
TAAG39), IL-6 (Forward: 59
AGTTGCCTTCTTGGGACTGA39; Reverse: 59 TCCAC-
GATTTCCCAGAGAAC39) and 18s (Forward: 59
GTAACCCGTTGAACCCCAT39; Reverse: 59 CCATC-
CAATCGGTAGTAGCG39). Results were normalized to 18s.
Macrophage Culture and Chemotaxis Assay
Mice were sacrificed in a CO2 chamber and hind limbs were
collected. Bone marrow derived macrophages (BMDMs) from WT
and RAGE2/2 mice were cultured as described previously [28]
with slight modification. Briefly, femoral bone marrow cells were
cultured in 75mm2 culture flasks in DMEM supplement with 10%
heat-inactivated FBS with 10% LADMAC supernatants, which
served as a source of M-CSF. Medium were changed as required.
Seven days later, macrophages were collected for experiments.
Chemotaxis assays were performed using the Boyden Chamber
system with modifications as described previously [28]. 56105
single cell suspension of BMDMs were seeded into 5.0 mm pore
size of TranswellH (Corning B.V. Life Sciences, Amsterdam,
Netherland) and cultured with different concentration of S100B
(Millipore, UK) for 20 hrs. Migrated cells from inserts to the
bottom chamber were counted. Five images were taken from the
centre, left, right, superior and inferior fields of view of the
chamber using an inverted microscopy. The average number of
cells from the five images was taken to represent the number of
migrated cells. All experiments were performed a minimum of
three times.
Statistical analysis. Student t test is used for two groups
comparison. For multiple groups comparison, a one way ANOVA
were performed first, then a Newman-Keuls multiple comparison
Figure 1. SD-OCT and histologial analysis of retina from one month RAGE 2/2mice (A, B), 9-month old RAGE 2/2mice (C, D), one
month old C57BL/6J mice (E, F) and 9-month old C57BL/6J mice (G, H). Retinal sections shows well-defined retinal structures from both
RAGE2/2 and C57BL/6J mice. Scale bar on A, C, D and F is 200 mm. The scale bar on B,D,E and F is 50 mm.
doi:10.1371/journal.pone.0089548.g001
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test were followed using Graph pad InStat 3.0 (GraphPad
Software, San Diego, CA, USA). All data were considered
significant at a level of p,0.05 and presented as mean +/2SEM.
Results
Retinal Degeneration is Not Present on WT or RAGE2/2
Mice
Typically, mice homozygous for Crb1rd8 mutation exhibit large
white retinal spots in the fundus images and a slow progressive
retinal degeneration [29,30]. However, not every strain which has
the rd8 mutation develops a retinal degeneration phenotype. For
example, Chang et al has demonstrated that only 23 strains out of
83 strains with the rd8 mutation demonstrated retinal degener-
ation [29]. We studied the histology and OCT of eyes of different
ages of RAGE2/2 mice (Fig. 1). The OCT retinal cross sections
showed hyper-reflective or hyporeflective interfaces representing
the normal layers of retinas. Eye sections showed normal
architecture with well-defined nuclear layer (GCL, INL and
ONL), synaptic layers, intact photoreceptors (inner and outer
segments) and the RPE. We were unable to detect any patches of
dysplasia, retinal folds or pseudorosettes which is morphology
typical of retinal degeneration caused by the rd8 mutation [31].
RAGE/ligand Axis Expression is Increased in CNV
Development
To determine the involvement of RAGE in CNV development,
eye sections were stained with RAGE antibody at different time
points post lasering in WT mice. Low levels of RAGE expression
were detected in the neuronal retina in the inner plexiform layer,
outer plexiform layer and in the inner segments of photoreceptor
(Fig. 2A). One day after laser treatment, the expression of RAGE
was markedly increased (Fig. 2B) and the expression levels
remained at high levels through to day 7 (Fig. 2C). RAGE-
immunoreactivity was also detected at the site of CNV (Fig. 2D).
Dual staining of CD68 and RAGE showed that RAGE is also
expressed by infiltrating CD68+ subretinal macrophages (Fig. 2E).
In the inner retina, activated microglia also expressed CD68
(Fig. 2F). Some of these CD68+ microglia expressed RAGE
(arrow, Fig. 2F) while other cells were negative for CD68
(arrowhead, Fig. 2F). Furthermore, RAGE mRNA levels were
significantly increased in the retina following CNV induction (p,
0.001) (Fig. 2G).
S100B is one of the main ligands of RAGE and under normal
physiological conditions this protein is expressed by astrocytes in
the retina [13] (Fig. 3A). However, following CNV induction in
WT retina, the expression of S100B was increased and could be
detected in the outer plexiform layer (arrowheads in Fig. 3B).
Furthermore, strong S100B expression were detected at the site of
CNV (Fig. 3B). S100B was significantly up-regulated in the lasered
WT retina when compared to non-lasered control retina (P,
0.001, Fig. 3C).
Genetic Deletion of RAGE Reduces CNV Lesion Size
RAGE expression is increased in the retina following CNV
induction. In particular, we have shown that there is increased
RAGE expression in infiltrating macrophage and local resident
macrophages (microglia). Therefore, we hypothesised that the
RAGE pathway may be involved in the development of CNV. To
test this, we studied the effect of RAGE deficiency on CNV lesions.
CNV was produced in 12 week-old WT and RAGE2/2 mice.
Upon examination by fundus photography and fluorescein
angiography there was no difference in the nature of the laser
burn and the associated leakage at day 0 between C67BL/6 and
RAGE2/2 mice (Figure 4A). Seven days post lasering, angiog-
raphy revealed a marked difference in the size of laser-induced
CNV lesions in the retina of RAGE2/2 mice when compared to
WT controls (Figure 4B). Post-mortem evaluation using confocal
microscopy of retinal flat-mounts, stained with isolectin B4,
demonstrated a significant reduction in CNV lesion size in the
RAGE2/2 mice when compared to WT counterparts (P,0.05)
(Figure 4C). The S100B expression did not show any alteration in
RAGE2/2 which had CNV induced (Fig. 3C).
Reduced Retinal Immune Cell Activation and Cytokine
Expression in RAGE2/2 Mice
RAGE is expressed by macrophages [32](Fig. 1E and 1F), and
infiltrating macrophages are known to play a critical role in CNV
formation [33,34]. To understand whether reduced CNV in
RAGE2/2 mice is related to macrophage infiltration/activation,
we then examined CNV-related immune cell function. Isolectin
and CD68 positive cells were present in the CNV lesions of both
WT and RAGE2/2 mice and both markers were often co-
localised, although some cells were present that expressed CD68
alone (Figure 5A). Isolectin-positive microglia or infiltrating
macrophages were quantified at the CNV lesion and also in
remote (non-lasered) retina. Isolectin-positive cells with a dendritic
phenotype were present in the non-lasered retina (remote from the
CNV lesion) and there was no difference between WT and
RAGE2/2 animals (Figure 5B). However at the CNV lesions,
WT animals displayed a significant shift towards amoeboid
(activated) cells when compared to non-lasered regions ((P,0.01)
(Figure 5C). RAGE2/2 animals also had more amoeboid cells at
CNV lesions but these were significantly less when compared to
WT counterparts (P,0.01) (Figure 5C).
In view of immune cell infiltration to the CNV lesions, retinal
mRNA expression of pro-inflammatory cytokines and VEGF was
investigated in the WT and RAGE2/2 groups (Figure 5). VEGF
was significantly increased in the WT retina where CNV was
present (P,0.001) although this response was significantly
suppressed in the RAGE2/2 mice (Figure 6). CNV also induced
mRNA expression in TNF-a, IL-1b, IL-6, MCP-1 and MCSF-1
when compared to normal, non-lasered retina (P,0.05–
0.01)(Figure 6). While baseline levels of some cytokine transcripts
were higher in RAGE2/2 mice when compared to WT (IL-1b,
IL-6 and MCP-1), there were consistently blunted CNV-induced
cytokine responses in the RAGE2/2 mice and in many cases
expression was reduced (Figure 6).
S100b Induces Macrophage Chemotaxis
Our results show that RAGE and S100B were increased in
laser-induced CNV and deletion of RAGE reduced lesion size
which was accompanied by decreased immune cell activation/
infiltration. This suggests that the RAGE-S100B pathway may
play an important role in macrophage infiltration following CNV
induction. To further test this observation, we conducted a
chemotaxis assay using BMDMs isolated from from WT and
RAGE2/2 mice. Cells from both donor mice had similar levels
of random migratory activity under normal culture conditions
(Fig. 7). However, in response to S100B, a dose-dependent
chemotactic migration was observed in BMDMs from WT mice
(p,0.05–0.001) but this response was not apparent in cells isolated
from RAGE2/2 mice (Fig. 7).
Discussion
RAGE plays an important role in inflammatory responses in
diseases such as Alzheimer’s, diabetic complications and acute
RAGE Regulates Choroidal Neovascularization
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lung injury [7]. Its sustained activation can change an acute
inflammatory response into prolonged inflammation that culmi-
nates in tissue damage [8] and, in some cases, immune cell-
mediated angiogenesis [35,36]. The current study has demon-
strated, for the first time, that RAGE could play an important
contributory role in immune cell activation within CNV lesions.
The reduction of CNV lesion size in RAGE2/2 mice is a key
finding of this study. While such laser-induced lesions do not
Figure 2. Rage expression in laser-treated eyes. Representative images demonstrating the RAGE expression at the eye sections from control
(A), day 1(B) day 5 (C) and day 7 (D) post-lasering in WT mice. Scale bar = 50 mm. E) Retinal section from day 5 post-laser mouse eye showing
macrophage (arrows) at the subretinal space express CD68 (red) and RAGE (green). Scale bar = 20 mm. F) Retinal section from day 5 post-laser mouse
eye showing CD68+ microglia at the ONL can be RAGE positive (arrow) or RAGE (arrowhead). Scale bar = 20 mm. G) RAGE mRNA expression in the
normal WT retina and laser-treated retina. RAGE mRNA level was significantly increased following laser treatment (n = 7 mice/group, P,0.001).
doi:10.1371/journal.pone.0089548.g002
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involve age-related pathology, this model is widely used to
reproduce key aspects of nvAMD [37]. S100B attracts macro-
phages to sites of injury and interestingly, RAGE2/2 mice have
this pro-inflammatory protein present at CNV lesions although
they demonstrate reduced immune cell infiltration and no
enhancement of pro-inflammatory cytokine expression. This is
probably due to suppressed S100B-RAGE activation and coin-
cides with a recent in vitro study in microglia demonstrating a
critical role for RAGE in S100B-mediated migration and
chemokine release [38]. S100B is a neurotrophic factor that
regulates cytosolic Ca2+ and cytoskeletal integrity in astrocytes,
oligodendrocytes, neural progenitors, Langerhans cells and
dendritic cells [21]. When it is secreted extracellularly S100B is
a potent pro-inflammatory factor that can activate macrophages
and evoke tissue damage [39]. In the retina, S100B is constitu-
tively expressed by astrocytes and Mu¨ller glia [22] although it is
upregulated in conditions such as diabetes [13] where it can
provoke inflammatory cytokine expression via RAGE-activation of
p44/42, p38, JNK and/or p90RSK [40].
The current study shows that the retinal expression of some
cytokines were at significantly higher baseline levels in
RAGE2/2 mice when compared to WT controls, an observation
that has been previously reported [24]. However, upon CNV
induction, there is no further increase in the expression of these
cytokines and often there is a significant decrease. The underlying
reason for this is unclear although the laser-induced immune
response in the RAGE2/2 may be shifted from a pro-
inflammatory to wound-healing/anti-inflammatory response with
accompanying changes in ratios of M1 to M2 macrophage
phenotypes in the lesion area. In addition, it may be related to the
regulatory role of RAGE in pro-inflammatory networks and
dependency of NF-kBp65. Absence of RAGE may initiate
different composition of NF-kB complexes in the absence of
RAGE and/or the interaction of NF-kB with different (e.g.
compensatory) cofactors could account for this phenomenon.
As a pattern-recognition receptor, RAGE binds many ligands
and several of these are relevant to the retina. For example, AGEs
occur in the ageing retina and these adducts are associated with
AMD [14]. While not a focus for the current study, AGEs could
Figure 3. S100B is present in CNV lesions. A) S100B expression in a normal WT mouse retina. Strong immunoreactivity is present in the
astrocytes (arrow). The position of the inner nuclear layer (INL) and outer nuclear layer (ONL) are indicted. Scale bar is 50 mm B) S100B expression in
WT mouse retinal at day 7 post-laser treatment. S100B was detected in the outer plexiform layer (arrowheads). Strong S100B expression was detected
at the site of CNV. Scale bar is 50 mm C) Real-time PCR demonstrates that S100B mRNA is significantly upregulated in retina with laser-induced CNV
lesions (n = 7 mice/group ***P,0.001). This increase is not observed in RAGE2/2 mice.
doi:10.1371/journal.pone.0089548.g003
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also play an important regulatory role in RAGE activation,
especially since they accumulate at the RPE-Bruch’s membrane
axis [41,42]. In the future, it would be important to determine how
RAGE could regulate pathology in ageing murine models which
Figure 4. Laser-induced CNV lesions are attenuated in RAGE2/2 mice. Representative images demonstrating laser-burned spots
immediately (A) and 7 days after photocoagulation (B) in RAGE2/2mice and WT controls. A) As assessed by cSLO, the retina from WT and RAGE2/2
mice shows laser burn sites immediately after photocoagulation. The left image in each pair is fluorescein angiography and the right image is infrared
reflectance. There is no obvious difference between the two animal groups with comparable leakage at the lesion (black arrow). B) 7 days after
photocoagulation the CNV lesions are apparent in angiograms and infrared reflectance fundus images from WT mice although these are smaller in
the retina of RAGE2/2 mice (white arrows). C) Comparison of CNV lesion size between the WT and RAGE2/2 mice. Retinal flat mounts were
evaluated for the presence and size of clearly demarcated isolectin positive CNV lesions one week post-laser injury. RAGE 2/2 mice exhibited
significantly less CNV than age matched controls (n = 12 animals/group, *p,0.05) (Scale bar = 100 mm).
doi:10.1371/journal.pone.0089548.g004
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show lesions characteristic of early-stage AMD. Related to this is
evidence that toll-like receptors (TLRs) play a role in inflamma-
tion-mediated pathology [43] and may be involved in retinopathy
[44,45]. The interaction between TLRs and RAGE is potentially
important and could contribute to innate immune responses in the
retina, especially since they share common ligand interactions with
S100 and HMGB1 [46].
Inflammation at the outer retina plays a major role in the
development of neovascular pathology in AMD [47]. Indeed,
activation of resident microglia and infiltration of immune cells
into the subretinal space are important aspects of the laser-induced
CNV response in mice [48,49] and it has been suggested that these
cells may be a driving force in the pathogenesis of AMD and not
simply a secondary consequence of primary RPE or photoreceptor
disease [50]. More recently, it has been suggested that a critical
population of infiltrating pro-inflammatory cells are M1 macro-
phages and contribute to AMD-like degenerative pathology in a
murine model [51]. RAGE plays a role regulation of monocyte
recruitment across the vasculature and into the inflamed brain
[52] and this receptor has been linked to migratory influx of
immune cells into tissues in association with up-regulation
adhesion molecules interactions [52,53]. In the current study we
show that S100B is a key stimulatory molecule that induces
migration of BMDMs and that this response was absent when
RAGE was deleted. This ‘‘ex vivo’’ assessment corresponds closely
to the observed responses of infiltration of CD68+ cells in the
Figure 5. RAGE regulates infiltration of microglia/macrophages to CNV lesions. A) The macrophage marker CD68 and isolectin (which
binds to microglia and macrophages) were used to assess immune cell infiltration into CNV lesions within the retina of WT and RAGE2/2 mice.
Representative images demonstrated that Isolectin-positvie cells sometimes co-locaslised with CD68 positive cells. Most isolectin-positive cells
demonstrated a dendritic morphology (arrow). (Scale bar = 50 mm). B) Microglia were quantified both in CNV lesions from WT and RAGE2/2 mice.
Isolectin-positive cells with a typically dendritic (inactive) morphology occurred at high numbers in retinas of non-lasered mice but only in the WT did
laser cause a reduction in this phenotype. (** P,0.01). Representative images are shown of typical dendritic and amoeboid microglial cell in the
retina. C). Active microglia (with an amoeboid phenotype) were higher in lasered WT and RAGE2/2 mice when compared to their non-lesioned
controls. RAGE2/2 mice had significantly fewer active microglia compared to WT mice (**P,0.01). n = 12 mice/group.
doi:10.1371/journal.pone.0089548.g005
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retina and activation of microglia in the retina post-CNV. The
role of RAGE on macrophage polarity is not well established,
although a recent study has suggested that S100B was secreted
from adipocytes and correlated with up-regulation of M1 markers
in RAW macrophages, a response prevented by RAGE neutral-
ization [54]. It would be worthwhile to dissect the relative
contribution of RAGE to immune cell infiltration in the context of
CNV, AMD and other retinal diseases that involve inflammation.
and these studies are currently ongoing in our laboratory.
Despite our mice showing no outer retinal degeneration, we
were concerned that the presence of the rd8 mutation (as a Crb1
deletion) could interfere with development of CNV. While
phenotype with the rd8 mutation is variable [29], CCL2(2/2)/
Cx3cr1(2/2)/Crb1 [55] and C57BL/6 CD11c-eYFP mice [56]
Figure 6. RAGE regulates growth factor and cytokine expression during CNV. CNV lesion induction in WT mice produces a profound
growth factor and cytokine response with VEGF, TNF-a, IL-1b, IL-6, MCP-1 and MCSF-1 all showing a significant up-regulation in comparison to
control (non-lasered) retina. The retina of RAGE2/2 animals appears to show a constitutively higher level of some cytokines when compared to WT
(IL-1b, IL-6 and MCP-1). Upon laser treatment, the retina from RAGE2/2 mouse retina shows a significantly suppressed VEGF and cytokine response
when compared to WT. (n = 7 mice/group, *P,0.05; **P,0.01; ***P,0.001).
doi:10.1371/journal.pone.0089548.g006
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show profound photoreceptor degeneration. This is accompanied
by enhanced macrophage activity in the outer retina indicating
that inflammation occurs in the presence of the rd8 mutation. The
development of CNV in animals requires infiltration of macro-
phages [57,58] and it could, perhaps, have been anticipated that
rd8 mutation would exacerbate laser-induced CNV in the
RAGE2/2 mice. In fact our data shows the opposite response.
We feel that the absence of photoreceptor degeneration in our
mice suggests that the mutation is minimally active and thus has
not played a major role in the reduced size of CNV in RAGE2/2
mice.
In summary, this investigation has demonstrated that RAGE
activation by S100B contributes to CNV by regulating angiogenic
activity, infiltration of immune cells to the lesion site and up-
regulation of pro-inflammatory cytokines. Our data builds on
previous reports that RAGE and some of its ligands are present in
the outer retina of aged patients [59] and provides compelling
evidence that use of agents that can attenuate RAGE signaling
could have utility for preventing the most visually disabling
manifestation of AMD.
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